Last reviewed · How we verify
E coli Vaccine 4 Dose A (e-coli-vaccine-4-dose-a)
At a glance
| Generic name | e-coli-vaccine-4-dose-a |
|---|---|
| Sponsor | Pfizer Inc. |
| Modality | Vaccine |
| Phase | Phase 1 |
Approved indications
Common side effects
- Injection Site Pain
- Headache
- Injection Site Induration
- Fatigue
- Myalgia
- Upper respiratory tract infection
- Malaise
- Nausea
- Nasopharyngitis
- Prothrombin time prolonged
- Neutropenia
- Gastritis
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- E coli Vaccine 4 Dose A CI brief — competitive landscape report
- E coli Vaccine 4 Dose A updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI